title: The Emory Chemical Biology Discovery Center: leveraging academic innovation to advance novel targets through HTS and beyond.
abstract: The Emory Chemical Biology Discovery Center (ECBDC) aims to accelerate high throughput biology and translation of biomedical research discoveries into therapeutic targets and future medicines by providing high throughput research platforms to scientific collaborators worldwide. ECBDC research is focused at the interface of chemistry and biology, seeking to fundamentally advance understanding of disease-related biology with its HTS/HCS platforms and chemical tools, ultimately supporting drug discovery. Established HTS/HCS capabilities, university setting, and expertise in diverse assay formats, including protein-protein interaction interrogation, have enabled the ECBDC to contribute to national chemical biology efforts, empower translational research, and serve as a training ground for young scientists. With these resources, the ECBDC is poised to leverage academic innovation to advance biology and therapeutic discovery.
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Johns
authors.forename: Cheryl L
authors.initials: CL
authors.lastname: Meyerkord-Belton
authors.forename: Yuhong
authors.initials: Y
authors.lastname: Du
authors.affiliation: Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, GA 30322, USA. hfu@emory.edu.
authors.forename: Haian
authors.initials: H
authors.lastname: Fu
mesh_terms: D019295:Computational Biology; D003299:Cooperative Behavior; D055808:Drug Discovery; D005845:Georgia; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D062069:Inventions; D010641:Phenotype; D015398:Signal Transduction; D014495:Universities / Q000458:organization & administration*